Search for: "S&S Food Corporation " Results 5761 - 5780 of 9,985
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Oct 2016, 3:57 pm
Gene specializes in litigation, arbitration and general corporate law for New York-based and international clients. [read post]
27 Aug 2021, 5:52 pm by Jenny Schell
Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. [read post]
14 Jun 2018, 9:40 am by Bruce Clark
The products were packaged in clear, plastic clamshell containers and distributed to Costco, Jay C, Kroger, Payless, Owen’s, Sprouts, Trader Joe’s, Walgreens, Walmart, and Whole Foods/Amazon. [read post]
18 Jul 2024, 6:10 am by Michael Geist
Left unstated in a reference to boycotts is that there have been efforts to ban “Zionist” supporting food services that risks leaving Jewish students without access to kosher food on campus. [read post]
2 Apr 2016, 10:43 am by Bill Marler
These days, Marler is considered the nation’s leading food safety lawyer. [read post]
26 Sep 2017, 9:19 pm by Coral Beach
The policy is based on a clause in federal law that protects trade secrets, referred to as “confidential corporate information” (CCI). [read post]
18 Oct 2011, 3:55 pm by Quinn Norton
They put together a plan for obtaining and guarding food. [read post]
28 May 2022, 11:48 am by Gene Takagi
Putin is using food as a powerful new weapon in his three-month-old war. [read post]
18 Nov 2009, 4:57 am
Fast. - US criminal liability for import of adulterated or misbranded food or drugs (China Law Blog) US: Patent term adjustment: 37 CFR § 1.704(b)'s three-month provision (Patent Docs) Products Amrix (Cyclobenzaprine) - US: Patent infringement suit commenced in response to Paragraph IV certification: Eurand Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
Fast. - US criminal liability for import of adulterated or misbranded food or drugs (China Law Blog) US: Patent term adjustment: 37 CFR § 1.704(b)’s three-month provision (Patent Docs)   Products Amrix (Cyclobenzaprine) – US: Patent infringement suit commenced in response to Paragraph IV certification: Eurand Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
Fast. - US criminal liability for import of adulterated or misbranded food or drugs (China Law Blog) US: Patent term adjustment: 37 CFR § 1.704(b)'s three-month provision (Patent Docs) Products Amrix (Cyclobenzaprine) - US: Patent infringement suit commenced in response to Paragraph IV certification: Eurand Inc. et al. v. [read post]
10 Mar 2014, 7:35 am
Senator Stanford’s vision may soon be realized if two members of of the California Assembly have their legislative way." [read post]
6 Jul 2016, 10:00 pm by Dan Flynn
” Murphy’s majority opinion makes a distinction between “vicarious liability,” where a supervisory party is held liable “for the actionable conduct of a subordinate” and the responsibilities of corporate officers under the Food Drug and Cosmetic Act (FDCA), where food company executives have the responsibility to”prevent or remedy” conditions. [read post]
17 Jan 2023, 11:20 am by admin
Amazon’s subsidiary Whole Foods surveils two dozen metrics among its 95,000 employees at more than 500 stores in order to predict stores’ risk of unionization. [read post]
15 Aug 2011, 8:54 am by William McGrath
Three executives were charged with insider trading for selling shares of Immunosyn Corporation (the company which made the false filings) for $20 million during the same period. [read post]
15 Jun 2021, 9:05 pm by Dan Flynn
(To sign up for a free subscription to Food Safety News, click here.) [read post]
29 Jul 2010, 8:16 am by Schachtman
  For a while, Thomas worked in the legal department of Monsanto Corporation, but he was unsettled by defending the company’s chemicals, which he believed were so dangerous to humans. [read post]
23 Jul 2017, 7:34 am by Bill Marler
Marler Clark, The Food Safety Law Firm, is the nation’s leading law firm representing victims of Salmonella outbreaks. [read post]
22 Sep 2006, 12:17 pm
Just the same, brand name biotech companies may want to get a hold of a copy of Cutting Edge Information's report "Combating Generics: Pharmaceutical Brand Defense for 2007," which includes strategies to retain market share and defend patents including, among others, patent litigation and authorized generics and corporate generics subsidiaries. [read post]